Your browser doesn't support javascript.
loading
Calreticulin mutations affect its chaperone function and perturb the glycoproteome.
Schürch, Patrick M; Malinovska, Liliana; Hleihil, Mohammad; Losa, Marco; Hofstetter, Mara C; Wildschut, Mattheus H E; Lysenko, Veronika; Lakkaraju, Asvin K K; Maat, Christina A; Benke, Dietmar; Aguzzi, Adriano; Wollscheid, Bernd; Picotti, Paola; Theocharides, Alexandre P A.
Afiliação
  • Schürch PM; Department of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland.
  • Malinovska L; Institute of Molecular Systems Biology (IMSB), Department of Biology, ETH Zurich, Zurich, Switzerland.
  • Hleihil M; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
  • Losa M; Institute of Neuropathology, University Hospital Zurich, Zurich, Switzerland.
  • Hofstetter MC; Department of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland.
  • Wildschut MHE; Department of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland; Institute of Molecular Systems Biology (IMSB), Department of Biology, ETH Zurich, Zurich, Switzerland; Institute of Translational Medicine (ITM), Department
  • Lysenko V; Department of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland.
  • Lakkaraju AKK; Institute of Neuropathology, University Hospital Zurich, Zurich, Switzerland.
  • Maat CA; Institute of Molecular Systems Biology (IMSB), Department of Biology, ETH Zurich, Zurich, Switzerland.
  • Benke D; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
  • Aguzzi A; Institute of Neuropathology, University Hospital Zurich, Zurich, Switzerland.
  • Wollscheid B; Institute of Translational Medicine (ITM), Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.
  • Picotti P; Institute of Molecular Systems Biology (IMSB), Department of Biology, ETH Zurich, Zurich, Switzerland.
  • Theocharides APA; Department of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland. Electronic address: alexandre.theocharides@usz.ch.
Cell Rep ; 41(8): 111689, 2022 11 22.
Article em En | MEDLINE | ID: mdl-36417879
ABSTRACT
Calreticulin (CALR) is an endoplasmic reticulum (ER)-retained chaperone that assists glycoproteins in obtaining their structure. CALR mutations occur in patients with myeloproliferative neoplasms (MPNs), and the ER retention of CALR mutants (CALR MUT) is reduced due to a lacking KDEL sequence. Here, we investigate the impact of CALR mutations on protein structure and protein levels in MPNs by subjecting primary patient samples and CALR-mutated cell lines to limited proteolysis-coupled mass spectrometry (LiP-MS). Especially glycoproteins are differentially expressed and undergo profound structural alterations in granulocytes and cell lines with homozygous, but not with heterozygous, CALR mutations. Furthermore, homozygous CALR mutations and loss of CALR equally perturb glycoprotein integrity, suggesting that loss-of-function attributes of mutated CALR chaperones (CALR MUT) lead to glycoprotein maturation defects. Finally, by investigating the misfolding of the CALR glycoprotein client myeloperoxidase (MPO), we provide molecular proof of protein misfolding in the presence of homozygous CALR mutations.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Calreticulina / Transtornos Mieloproliferativos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Calreticulina / Transtornos Mieloproliferativos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article